Home/Filings/4/0001387131-19-006606
4//SEC Filing

Krassan Mitchell 4

Accession 0001387131-19-006606

CIK 0000025743other

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 9:49 PM ET

Size

5.7 KB

Accession

0001387131-19-006606

Insider Transaction Report

Form 4
Period: 2019-08-28
Krassan Mitchell
EVP, Chief Strategy Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-08-28+300,000300,000 total
    Exercise: $2.73From: 2020-08-28Exp: 2029-08-28Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]Underlying shares vest as follows: 100,000 shares on the first anniversary date of the grant, 100,000 shares on the second anniversary date of the grant, and 100,000 shares on the third anniversary date of the grant.

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001532232

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 9:49 PM ET
Size
5.7 KB